Retrospective Study
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Oncol. Apr 15, 2024; 16(4): 1256-1267
Published online Apr 15, 2024. doi: 10.4251/wjgo.v16.i4.1256
Computed tomography-based radiomics diagnostic approach for differential diagnosis between early- and late-stage pancreatic ductal adenocarcinoma
Shuai Ren, Li-Chao Qian, Ying-Ying Cao, Marcus J Daniels, Li-Na Song, Ying Tian, Zhong-Qiu Wang
Shuai Ren, Ying-Ying Cao, Li-Na Song, Ying Tian, Zhong-Qiu Wang, Department of Radiology, Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing 210029, Jiangsu Province, China
Li-Chao Qian, Department of Geratology, Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Nanjing 210022, Jiangsu Province, China
Marcus J Daniels, Department of Radiology, NYU Langone Health, New York, NY 10016, United States
Co-first authors: Shuai Ren and Li-Chao Qian.
Co-corresponding authors: Ying Tian and Zhong-Qiu Wang.
Author contributions: Ren S and Qian LC contributed equally to this work; Ren S, Tian Y, and Wang ZQ designed the research study; Ren S, Qian LC, and Cao YY performed the research; Ren S, Qian LC, and Song LN analyzed the data; Ren S and Qian LC wrote the manuscript; Daniels MJ, Tian Y, and Wang ZQ revised the manuscript; and all authors read and approved the final manuscript. Tian Y and Wang ZQ contributed equally to this work as co-corresponding authors due to the fact that they contributed efforts of equal substance throughout the research process, such as facilitating communication with the journal, handling revisions, and addressing queries. Indeed, we believe that designating Tian Y and Wang ZQ as co-corresponding authors is fitting for our manuscript as it accurately reflects our team’s collaborative spirit, equal contributions, and diversity.
Supported by the National Natural Science foundation of China, No. 82202135, 82371919, 82372017, and 82171925; China Postdoctoral Science Foundation, No. 2023M741808; Young Elite Scientists Sponsorship Program by Jiangsu Association for Science and Technology, No. JSTJ-2023-WJ027; Foundation of Excellent Young Doctor of Jiangsu Province Hospital of Chinese Medicine, No. 2023QB0112; Nanjing Postdoctoral Science Foundation, Natural Science Foundation of Nanjing University of Chinese Medicine, No. XZR2023036 and XZR2021050; and Medical Imaging Artificial Intelligence Special Research Fund Project, Nanjing Medical Association Radiology Branch, Project of National Clinical Research Base of Traditional Chinese Medicine in Jiangsu Province, China, No. JD2023SZ16.
Institutional review board statement: The study was reviewed and approved by the ethics committee of Affiliated Hospital of Nanjing University of Chinese Medicine (Approval No. 2017NL-137-05).
Informed consent statement: Informed consent statement was waived due to the retrospective nature of the study.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Data sharing statement: Patient imaging data and histopathology reports contain sensitive patient information and cannot be released publicly due to the legal and ethical restrictions imposed by the institutional ethics committee (Affiliated Hospital of Nanjing University of Chinese Medicine). Data is available upon reasonable request from the following e-mail address: zhongqiuwang@njucm.edu.cn.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Zhong-Qiu Wang, MD, PhD, Deputy Director, Professor, Department of Radiology, Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, No. 155 Hanzhong Road, Nanjing 210029, Jiangsu Province, China. zhongqiuwang0815@163.com
Received: November 5, 2023
Peer-review started: November 5, 2023
First decision: December 20, 2023
Revised: December 27, 2023
Accepted: February 1, 2024
Article in press: February 1, 2024
Published online: April 15, 2024
Processing time: 157 Days and 22 Hours
ARTICLE HIGHLIGHTS
Research background

Pancreatic ductal adenocarcinoma (PDAC) remains the deadliest of the common cancers, with little change in patient survival in the past several decades. One of the biggest challenges of the management of PDAC that physicians often encounter is that the early detection in high-risk individuals and the early diagnosis of patients with suspected symptoms. Precise staging of PDAC is vital not only in making treatment decisions, but also in evaluating prognosis.

Research motivation

Radiomics, the generation of minable high throughput data through conversion of digital computed tomography (CT) or magnetic resonance imaging images, allows obtaining additional insight into pancreatic tissue heterogeneity. CT-based radiomics diagnostic approach could serve as a promising non-invasive method in differential diagnosis between early- and late-stage PDAC.

Research objectives

This study aimed to develop a radiomics-based diagnostic approach with a robust noninvasive diagnostic potential for identifying patients with early-stage PDAC.

Research methods

A total of 71 patients with pathologically proved PDAC based on surgical resection who underwent contrast-enhanced-CT within 30 d prior to surgery were included in the study. Radiomics features were extracted from the region of interest (ROI) for each patient using Analysis Kit software. The most important and predictive radiomics features were selected using Mann-Whitney U test, univariate logistic regression analysis, and minimum redundancy maximum relevance (MRMR) method. Random forest (RF) method was used to construct the radiomics model, and 10-times leave group out cross-validation (LGOCV) method was used to validate the robustness and reproducibility of the model.

Research results

A total of 792 radiomics features (396 from late arterial phase and 396 from portal venous phase) were extracted from the ROI for each patient. Nine most important and predictive features were selected using Mann-Whitney U test, univariate logistic regression analysis, and MRMR method. RF method was used to construct the radiomics model with the nine most predictive radiomics features, which showed a high discriminative ability with 97.7% accuracy, 97.6% sensitivity, 97.8% specificity, 98.4% positive predictive value, and 96.8% negative predictive value. The radiomics model was proved to be robust and reproducible using 10-times LGOCV method with an average area under the curve of 0.75 by the average performance of the 10 newly built models.

Research conclusions

This study demonstrated that CT-based radiomics diagnostic approach could be used to differentiate between early- and late-stage PDAC.

Research perspectives

This study developed a radiomics-based diagnostic approach with a robust noninvasive diagnostic potential for identifying patients with early-stage PDAC. Large-scale prospective cohort studies, preferably multi-center, to validate the potential value of the radiomics diagnostic approach in differentiating early from late stage PDAC are in order.